Intersecting Endocrine Pathways in Cardiomyopathy: The Role of Metabolic Burden in Structural Heart Disease

Ovidiu Țica1,2, Mircea Ioan Șandor3, Anca Huniadi3

  • 1Department of Morphological Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.

Biomedicines
|October 29, 2025
PubMed

Insights

Non-insulin-treated diabetes and hypothyroidism significantly increase the risk of dilated cardiomyopathy (DCM). A metabolic burden score combining these factors aids in stratifying DCM and readmission risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Syndrome

Background:

  • Dilated cardiomyopathy (DCM) is a primary cause of heart failure morbidity and mortality.
  • The combined impact of type 2 diabetes mellitus (T2DM), obesity, and thyroid dysfunction on DCM is not well understood.
  • These conditions are individually linked to cardiovascular disease.

Purpose of the Study:

  • To assess the independent and combined associations of diabetes, thyroid dysfunction, and obesity with DCM prevalence.
  • To evaluate the impact of these metabolic factors on 30-day hospital readmission rates.
  • To examine the utility of a composite Metabolic Burden Score for risk stratification.

Main Methods:

  • Retrospective analysis of 1079 adult patients' electronic health records.
  • Multivariable logistic regression with ridge regularization to identify DCM predictors.
  • Stratification of endocrine phenotypes and development of a 3-point Metabolic Burden Score.

Main Results:

  • DCM prevalence was 46%; non-insulin-treated diabetes (OR 6.93) and hypothyroidism (OR 1.78) were independent predictors.
  • Obesity contributed to DCM risk within the Metabolic Burden Score.
  • DCM prevalence increased with the score, reaching 50% in the high-risk group; moderate-risk patients had the highest readmission rate (42.8%).

Conclusions:

  • Non-insulin-treated diabetes and hypothyroidism are significant metabolic drivers of DCM.
  • A composite Metabolic Burden Score effectively stratifies risk for DCM and early hospital readmission.
  • Integrated endocrine-cardiac screening can improve early detection and prevention of structural heart disease.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
492
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.4K